About this trial
The project is a national, prospective, multicenter, observational pilot project of screening CTEPH in pacients after APE in the Czech Republic. The main goal of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of Chronic tromboembolic pulmonary hypertesion in such a way as to ensure the maximum positive impact on the health of the population and high cost-effectiveness of the whole process.
Eligibility criteria
Qualifiers
Age over 18 years
Signed consent to participate in the project and GDPR
Patients with new-onset and ongoing or progressive dyspnea (min. NYHA II) after a pulmonary embolism episode or worsening of dyspnea after a pulmonary embolism episode compared to the status before the episode (at least 1 HYHA grade) or
ECHO evidence of severe PH at diagnosis of PE (PASP >60 mmHg)
Disqualifiers
Not agreeing to participate in the project
Contraindications to treatment
Trial design
Treatments tested in this trial
- Standardized CTEPH Screening Protocol
Treatment groups
Sponsors and collaborators
Institute of Health Information and Statistics of the Czech Republic
Lead sponsor
General University Hospital, Prague
Collaborator